Investing
Top Analyst Downgrades and Stocks to Sell: CVS, DaVita, Zillow and More
Published:
Last Updated:
Investors frequently get to see the analyst upgrades and Buy ratings from Wall Street firms. What investors often do not get to see is when analyst downgrade stocks to sell or to avoid. 24/7 Wall St. reviews many fresh research calls each and every day to find great ideas from value stocks to growth stocks to dividend stocks, and we have broken out the negative analyst calls. These are this Wednesday’s top analyst downgrades and cautious research notes from Wall Street.
CVS Caremark Corp. (NYSE: CVS) was downgraded to Hold from Buy at Cantor Fitzgerald.
DaVita Healthcare Partners Inc. (NYSE: DVA) was downgraded to Sector Perform from Outperform at RBC Capital Markets.
Endeavour International Corp. (NYSE: END) was downgraded to Hold from Buy at Canaccord Genuity.
Endo Health Solutions Inc. (NASDAQ: ENDP) was downgraded to Sell from an already cautious Neutral rating at Janney.
Five Oaks Investment Corp. (NYSE: OAKS) was downgraded to Neutral from Outperform at Credit Suisse.
Marathon Oil Corp. (NYSE: MRO) was downgraded to Neutral from Buy at BofA/Merrill Lynch.
Zillow Inc. (NASDAQ: Z) was downgraded to Sector Perform from Outperform at RBC Capital Markets.
Want to Retire Early? Start Here (Sponsor)
Want retirement to come a few years earlier than you’d planned? Or are you ready to retire now, but want an extra set of eyes on your finances?
Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Have questions about retirement or personal finance? Email us at [email protected]!
By emailing your questions to 24/7 Wall St., you agree to have them published anonymously on a673b.bigscoots-temp.com.
By submitting your story, you understand and agree that we may use your story, or versions of it, in all media and platforms, including via third parties.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
